See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Donald Trump
Trade War
Baseball
Social Media
Natural Disasters
Artificial Intelligence
Senate
Republican Party
Trade
Stock Markets
Golf
Published • loading... • Updated

Sotatercept Lowers Risk of Major PAH Outcomes in Phase 3 ZENITH Trial

Summary by hcplive.com
Patients with PAH saw a 76% reduction in the composite of morbidity and mortality outcomes with sotatercept treatment.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

3 Articles

All
Left
Center
Right
drugtopics.comdrugtopics.com

Sotatercept Reduces Risk of Major Morbidity, Mortality for Pulmonary Arterial Hypertension

Patients with pulmonary arterial hypertension (PAH) received the maximum tolerated dose of background therapy with sotatercept or the placebo to the therapy.

Read Full Article
Pulmonary Hypertension NewsPulmonary Hypertension News

Winrevair reduces risk of death, transplant, hospitalization in...

Winrevair (sotatercept-csrk) significantly reduced the risk of death, lung transplant, or hospitalization in people with PAH.

Read Full Article
hcplive.comhcplive.com

Sotatercept Lowers Risk of Major PAH Outcomes in Phase 3 ZENITH Trial

Patients with PAH saw a 76% reduction in the composite of morbidity and mortality outcomes with sotatercept treatment.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

hcplive.com broke the news in on Tuesday, April 1, 2025.
Sources are mostly out of (0)

Similar News Topics

Merck

Merck

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal